Immediate Impact

40 standout
Sub-graph 1 of 16

Citing Papers

Invasive candidiasis
2024 Standout
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023 Standout
2 intermediate papers

Works of Kei Yane being referenced

Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).
2018
Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).
2018
and 1 more

Author Peers

Author Last Decade Papers Cites
Kei Yane 529 466 493 62 702
Shin‐E Wang 466 301 467 54 630
Yunqiang Cai 473 348 483 72 706
Bing Peng 502 398 555 63 750
On Suzuki 539 332 473 44 719
Kwang Yeol Paik 433 332 392 50 599
Toshifumi Kin 582 477 517 68 744
Isabel Fabra 530 335 490 60 773
Hipólito Durán 412 274 356 54 627
E. Bardaxoglou 470 316 359 37 624
Chang-Sup Lim 455 265 427 49 614

All Works

Loading papers...

Rankless by CCL
2026